Uncover key drivers, emerging technologies, and competitive movements shaping the celiac disease market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Celiac Disease Market in 2030?
The celiac disease market has experienced substantial expansion in recent years. Projections indicate its value will increase from $0.78 billion in 2025 to $0.87 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this expansion has been driven by factors such as increased autoimmune disease awareness, advancements in diagnostics, broader adoption of dietary management, enhanced hospital gastroenterology care, and active patient advocacy.
The celiac disease market is projected to experience substantial expansion in the coming years, reaching $1.27 billion by 2030, progressing at a compound annual growth rate (CAGR) of 10.0%. This anticipated growth is driven by factors such as the development of new drugs, advancements in gluten-free food products, tailored nutrition approaches, the implementation of early screening initiatives, and ongoing microbiome research. Key trends during this period are expected to encompass an increase in the adoption of gluten-free diets, the expanding market for packaged gluten-free foods, the broadening of drug-centric therapies, enhanced disease awareness and diagnostic efforts, and a strong emphasis on microbiome-focused treatments.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp
What Drivers Are Influencing Production Trends In The Celiac Disease Market?
The future expansion of personalized medicine is projected to propel the advancement of the celiac disease market. This medical strategy tailors healthcare solutions according to an individual’s unique genetic makeup, environmental factors, and lifestyle choices. A growing demand for personalized medicine stems from the wider accessibility of genetic testing, facilitating more precise diagnoses and therapeutic interventions customized for each patient’s requirements. The advancement of personalized medicine aids celiac disease treatment by enabling the accurate identification of genetic indicators and specific immune reactions, resulting in more focused and efficacious management plans for individual patients. An illustrative example is that in February 2024, data from the Personalized Medicine Coalition, a US-based nonprofit entity, showed that the FDA granted authorization to 16 personalized therapies in 2023 for rare diseases, marking an increase from the 6 approved in 2022. Consequently, the expansion of personalized medicine is set to invigorate the celiac disease market’s growth.
Which Segments Are Gaining Traction In The Celiac Disease Market?
The celiac disease market covered in this report is segmented –
1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments
2) By Route Of Administration: Oral, Parenteral
3) By End Users: Hospitals, Homecare, Other End-Users
Subsegments:
1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy
2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages
3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators
How Are New Market Trends Shaping The Landscape Of The Celiac Disease Market?
Leading companies within the celiac disease market are concentrating on creating sophisticated treatments, including anti-interleukin-15 (IL-15) antibodies, aimed at lessening tissue damage by moderating overactive immune cell function. These anti-interleukin-15 (IL-15) antibodies are specialized proteins designed to impede the IL-15 cytokine’s action, thereby assisting in the regulation of immune system activity and inflammation. As an illustration, Teva Pharmaceutical Industries, an Israeli pharmaceutical firm, declared in May 2025 that the U.S. Food and Drug Administration had designated TEV-53408, an experimental anti-interleukin-15 (IL-15) antibody, with Fast Track status. This investigational monoclonal antibody is being developed for celiac disease patients who adhere to a gluten-free diet. Its mode of action involves obstructing interleukin-15 (IL-15), a molecule crucial in initiating the immune response that results in intestinal damage for individuals with celiac disease. The treatment is presently undergoing assessment in a Phase 2a clinical trial to determine both its safety and effectiveness.
Who Are The Prominent Global Companies Shaping The Celiac Disease Market Landscape?
Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report
Which Geographic Areas Are Emerging As Strong Markets For The Celiac Disease Market?
North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Celiac Disease Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24497&type=smp
Browse Through More Reports Similar to the Global Celiac Disease Market 2026, By The Business Research Company
Rare Diseases Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Rare Disease Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report
Rare Inflammatory Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model